CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Faeth gets new Buy at Guggenheim on lead asset

Positive
AI Analysis

Summary

Guggenheim initiated coverage of Faeth with a Buy rating, citing the company's lead asset as a key investment driver.

Importance:3/10
Sentiment:
0.60
analyst_ratingbuy_rating

Read the original article

Published by Seeking Alpha Healthcare on September 16, 2026 5:02 PM

Read Original